WO2012060793A3 - Process for the preparation of cefdinir formulations - Google Patents
Process for the preparation of cefdinir formulations Download PDFInfo
- Publication number
- WO2012060793A3 WO2012060793A3 PCT/TR2011/000258 TR2011000258W WO2012060793A3 WO 2012060793 A3 WO2012060793 A3 WO 2012060793A3 TR 2011000258 W TR2011000258 W TR 2011000258W WO 2012060793 A3 WO2012060793 A3 WO 2012060793A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- cefdinir
- formulations
- cefdinir formulations
- processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to processes to be used for preparation of formulations comprising cefdinir as the active agent and pharmaceutical compositions to be obtained by this process.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/09167 | 2010-11-05 | ||
TR2010/09167A TR201009167A2 (en) | 2010-11-05 | 2010-11-05 | Pharmaceutical granules containing cephalosporin. |
TR2010/10860A TR201010860A2 (en) | 2010-11-05 | 2010-12-24 | Production method for cefdinir formulations. |
TR2010/10860 | 2010-12-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012060793A2 WO2012060793A2 (en) | 2012-05-10 |
WO2012060793A3 true WO2012060793A3 (en) | 2012-06-28 |
Family
ID=45607339
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2011/000258 WO2012060793A2 (en) | 2010-11-05 | 2011-11-03 | Process for the preparation of cefdinir formulations |
PCT/TR2011/000254 WO2012060789A2 (en) | 2010-11-05 | 2011-11-03 | Production method for cefdinir formulations |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2011/000254 WO2012060789A2 (en) | 2010-11-05 | 2011-11-03 | Production method for cefdinir formulations |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR201010860A2 (en) |
WO (2) | WO2012060793A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0281200A1 (en) * | 1987-03-02 | 1988-09-07 | Yamanouchi Europe B.V. | Pharmaceutical composition, pharmaceutical granulate and process for their preparation |
CA2393614A1 (en) * | 2002-07-19 | 2002-10-28 | Abbott Laboratories | Antibacterial clarithromycin compositions and processes for making the same |
WO2004006917A1 (en) * | 2002-07-16 | 2004-01-22 | Ranbaxy Laboratories Limited | Dispersible tablets for oral administration |
WO2005115347A1 (en) * | 2004-05-31 | 2005-12-08 | Sam-A Pharmaceuticals Co., Ltd. | Dispersible tablet comprising beta lactam antibiotics and process for preparing the same |
WO2007058397A1 (en) * | 2005-11-17 | 2007-05-24 | Gl Pharmtech Corp. | A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA836918B (en) | 1982-09-30 | 1984-05-30 | Fujisawa Pharmaceutical Co | 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same |
-
2010
- 2010-12-24 TR TR2010/10860A patent/TR201010860A2/en unknown
-
2011
- 2011-11-03 WO PCT/TR2011/000258 patent/WO2012060793A2/en active Application Filing
- 2011-11-03 WO PCT/TR2011/000254 patent/WO2012060789A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0281200A1 (en) * | 1987-03-02 | 1988-09-07 | Yamanouchi Europe B.V. | Pharmaceutical composition, pharmaceutical granulate and process for their preparation |
WO2004006917A1 (en) * | 2002-07-16 | 2004-01-22 | Ranbaxy Laboratories Limited | Dispersible tablets for oral administration |
CA2393614A1 (en) * | 2002-07-19 | 2002-10-28 | Abbott Laboratories | Antibacterial clarithromycin compositions and processes for making the same |
WO2005115347A1 (en) * | 2004-05-31 | 2005-12-08 | Sam-A Pharmaceuticals Co., Ltd. | Dispersible tablet comprising beta lactam antibiotics and process for preparing the same |
WO2007058397A1 (en) * | 2005-11-17 | 2007-05-24 | Gl Pharmtech Corp. | A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
TR201010860A2 (en) | 2012-05-21 |
WO2012060789A2 (en) | 2012-05-10 |
WO2012060789A3 (en) | 2012-06-28 |
WO2012060793A2 (en) | 2012-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012021715A3 (en) | Stable formulations of linaclotide | |
WO2011093832A3 (en) | Stable efervescent formulations comprising cefaclor | |
WO2014014835A8 (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
WO2010092090A3 (en) | Novel salts of sitagliptin | |
WO2011017502A3 (en) | Linaclotide-containing formulations for oral administration | |
WO2011130615A3 (en) | Preparation of lacosamide | |
WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
WO2011157720A3 (en) | Ivabradine-containing pharmaceutical composition with modified release | |
WO2010139979A3 (en) | Processes for preparing crystalline forms of dasatinib | |
WO2012037562A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
WO2012040804A3 (en) | Synergistic combinations of triazoles, strobilurins and benzimidazoles, uses, formulations, production processes and applications using the same | |
WO2014203275A3 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
WO2014068586A3 (en) | Solid oral compositions of tolvaptan | |
EP2583969A4 (en) | Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients | |
ZA201500362B (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
MX339361B (en) | Alternan derivatives. | |
WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
WO2011139249A3 (en) | Pharmaceutical composition comprising cefdinir | |
WO2011045774A3 (en) | Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof | |
WO2010061220A3 (en) | Novel processes and pure polymorphs | |
WO2011093831A3 (en) | Effervescent formulations comprising cefprozil as active agent | |
WO2011095985A3 (en) | Rasagiline salts and processes for the preparation thereof | |
WO2012122451A3 (en) | Polymorphs of maxacalcitol and process for the preparation of maxacalcitol | |
MX2013012773A (en) | Drug substances, pharmeceutical compositions and methods for preparing the same. | |
EP2568810A4 (en) | Darunavir compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11817553 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11817553 Country of ref document: EP Kind code of ref document: A2 |